ERBB2 and breast ductal adenocarcinoma: We used an established cell line from an ER-/PR-/HER2+ primary ductal carcinoma (CRL2338/HCC1954) as well as immortalized normal B-lymphoblasts isolated from the same patient as a control (CRL2339/HCC1954BL).